PROSE_2B: PROSE, figure 2B

PROSE_2BR Documentation

PROSE, figure 2B

Description

Kaplan-Meier digitized data from PROSE, figure 2B (PMID 24831979). A reported sample size of 142 for a primary endpoint of OS in lung cancer.

Usage

PROSE_2B

Format

A data frame of 263 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (chemo, erlotinib)

Source

Gregorc V, Novello S, Lazzari C, et al. Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial. Lancet Oncol 2014; 15: 713–21.

Examples

summary(PROSE_2B)

kmplot(PROSE_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.